We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STUB:NYSEStubHub Holdings, Inc. Analysis

Data as of 2026-05-03 - not real-time

$7.63

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

StubHub is trading at roughly $7.63, well below its 30‑day simple moving average of $6.91 and the 50‑day average of $7.50, but still far under the 200‑day average of $12.58, indicating a long‑term bearish backdrop. Technical momentum shows a bullish MACD histogram (+0.15) and an RSI of 58, suggesting limited downside pressure and a potential short‑term rebound toward the $7.70 resistance zone. Volatility remains high at 56% over the past month and beta is elevated at 1.74, reflecting a stock that moves sharply with market swings. Fundamentally, the company appears deeply undervalued – the discounted cash‑flow model prices the business at $24.35, implying a 62% upside from current levels, and the forward P/E of 5.9 is dramatically below the industry average of 18.9. However, earnings are still negative (trailing EPS –$6.27) and profit margins are in the red, though free cash flow of $0.67 bn and operating cash flow of $0.19 bn provide a cushion. The balance sheet is strained with a debt‑to‑equity ratio near 80% and total debt exceeding cash, adding leverage risk.
Recent material news adds a mixed overlay: a partnership with vivenu promises broader ticket distribution and could lift top‑line growth, while an FTC lawsuit over pricing transparency raises regulatory uncertainty. Analyst sentiment remains supportive (13 analysts averaging a “Buy” with median target $11), but the ongoing legal exposure and high leverage temper enthusiasm. Investors should weigh the sizable upside against the near‑term volatility, regulatory headwinds, and the need for a turnaround in profitability before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram indicating possible near‑term price lift
  • Decreasing volume and bearish longer‑term trend signal caution
  • Regulatory uncertainty from the FTC lawsuit

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF‑derived fair value suggests ~62% upside
  • Forward EPS turning positive and analyst consensus of “Buy”
  • Strategic partnership with vivenu expanding distribution channels

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term undervaluation relative to industry peers
  • Strong free cash flow generation despite current losses
  • Potential resolution of FTC case and continued market recovery for live events

Key Metrics & Analysis

Financial Health

Revenue Growth-15.80%
Profit Margin-109.21%
P/E Ratio5.9
ROE-115.61%
ROA-16.09%
Debt/Equity79.89
P/B Ratio2.2
Op. Cash Flow$192.6M
Free Cash Flow$674.9M
Industry P/E18.9

Technical Analysis

TrendBearish
RSI58.0
Support$5.74
Resistance$7.70
MA 20$6.91
MA 50$7.50
MA 200$12.58
MACDBullish
VolumeDecreasing
Fear & Greed Index91.09

Valuation

Fair Value$24.35
Target Price$12.37
Upside/Downside62.06%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.74
Volatility56.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.